These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24039598)

  • 1. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional variants of TNFAIP3 are associated with systemic lupus erythematosus in a cohort of Chinese Han population.
    Xu M; Gao W; Wu L; Liu X; Yu D; Shi X; Liu X; Wang Q; Fu X; Yu J; Xu B; Wang S
    Hum Immunol; 2019 Feb; 80(2):140-145. PubMed ID: 30529365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus.
    Wang S; Wen F; Tessneer KL; Gaffney PM
    Genes Immun; 2016 Apr; 17(3):165-70. PubMed ID: 26821284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.
    Adrianto I; Wen F; Templeton A; Wiley G; King JB; Lessard CJ; Bates JS; Hu Y; Kelly JA; Kaufman KM; Guthridge JM; Alarcón-Riquelme ME; ; Anaya JM; Bae SC; Bang SY; Boackle SA; Brown EE; Petri MA; Gallant C; Ramsey-Goldman R; Reveille JD; Vila LM; Criswell LA; Edberg JC; Freedman BI; Gregersen PK; Gilkeson GS; Jacob CO; James JA; Kamen DL; Kimberly RP; Martin J; Merrill JT; Niewold TB; Park SY; Pons-Estel BA; Scofield RH; Stevens AM; Tsao BP; Vyse TJ; Langefeld CD; Harley JB; Moser KL; Webb CF; Humphrey MB; Montgomery CG; Gaffney PM
    Nat Genet; 2011 Mar; 43(3):253-8. PubMed ID: 21336280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus.
    Musone SL; Taylor KE; Lu TT; Nititham J; Ferreira RC; Ortmann W; Shifrin N; Petri MA; Kamboh MI; Manzi S; Seldin MF; Gregersen PK; Behrens TW; Ma A; Kwok PY; Criswell LA
    Nat Genet; 2008 Sep; 40(9):1062-4. PubMed ID: 19165919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.
    Fan Y; Tao JH; Zhang LP; Li LH; Ye DQ
    Int J Immunogenet; 2011 Apr; 38(2):151-9. PubMed ID: 21208380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population.
    Liu Y; Dan G; Wu L; Chen G; Wu A; Zeng P; Xu W
    PLoS One; 2014; 9(7):e103104. PubMed ID: 25050625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.
    Altonsy MO; Sasse SK; Phang TL; Gerber AN
    J Biol Chem; 2014 Mar; 289(12):8231-9. PubMed ID: 24500711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.
    Zhou XJ; Lu XL; Nath SK; Lv JC; Zhu SN; Yang HZ; Qin LX; Zhao MH; Su Y; Shen N; Li ZG; Zhang H;
    Arthritis Rheum; 2012 Jan; 64(1):222-31. PubMed ID: 21905002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Autoimmune Disease-Associated Risk Variant in the
    Lou L; Bao W; Liu X; Song H; Wang Y; Zhang K; Gao W; Li H; Tu Z; Wang S
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study.
    Kawasaki A; Ito S; Furukawa H; Hayashi T; Goto D; Matsumoto I; Kusaoi M; Ohashi J; Graham RR; Matsuta K; Behrens TW; Tohma S; Takasaki Y; Hashimoto H; Sumida T; Tsuchiya N
    Arthritis Res Ther; 2010; 12(5):R174. PubMed ID: 20849588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
    Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
    Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the tandem polymorphisms (rs148314165, rs200820567) in TNFAIP3 with chronic hepatitis B virus infection in Chinese Han population.
    Li N; Shi Y; Zhang P; Sang J; Li F; Deng H; Lv Y; Han Q; Liu Z
    Virol J; 2017 Aug; 14(1):148. PubMed ID: 28784141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
    Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus.
    Graham RR; Cotsapas C; Davies L; Hackett R; Lessard CJ; Leon JM; Burtt NP; Guiducci C; Parkin M; Gates C; Plenge RM; Behrens TW; Wither JE; Rioux JD; Fortin PR; Graham DC; Wong AK; Vyse TJ; Daly MJ; Altshuler D; Moser KL; Gaffney PM
    Nat Genet; 2008 Sep; 40(9):1059-61. PubMed ID: 19165918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.